Multiomics Investigation Revealing the Characteristics of HIV-1-Infected Cells In Vivo.

Cell Reports
Hirofumi AsoKei Sato

Abstract

For eradication of HIV-1 infection, it is important to elucidate the detailed features and heterogeneity of HIV-1-infected cells in vivo. To reveal multiple characteristics of HIV-1-producing cells in vivo, we use a hematopoietic-stem-cell-transplanted humanized mouse model infected with GFP-encoding replication-competent HIV-1. We perform multiomics experiments using recently developed technology to identify the features of HIV-1-infected cells. Genome-wide HIV-1 integration-site analysis reveals that productive HIV-1 infection tends to occur in cells with viral integration into transcriptionally active genomic regions. Bulk transcriptome analysis reveals that a high level of viral mRNA is transcribed in HIV-1-infected cells. Moreover, single-cell transcriptome analysis shows the heterogeneity of HIV-1-infected cells, including CXCL13high cells and a subpopulation with low expression of interferon-stimulated genes, which can contribute to efficient viral spread in vivo. Our findings describe multiple characteristics of HIV-1-producing cells in vivo, which could provide clues for the development of an HIV-1 cure.

References

Sep 12, 1998·Journal of Virology·H MiyoshiI M Verma
May 3, 2002·Nature·Daniel C DouekRichard A Koup
Aug 31, 2002·Cell·Astrid R W SchröderFrederic Bushman
Oct 31, 2002·The Journal of Biological Chemistry·Peter CherepanovZeger Debyser
Jun 11, 2003·The Journal of Biological Chemistry·Goedele MaertensYves Engelborghs
Nov 29, 2005·Nature Medicine·Angela CiuffiFrederic Bushman
Sep 9, 2006·Science·Manuel LlanoEric M Poeschla
Jul 5, 2008·Cancer Cell·Akihiko Yokoyama, Michael L Cleary
May 20, 2009·Bioinformatics·Heng Li, Richard Durbin
May 29, 2009·BMC Bioinformatics·Weijun LuoPeter J Woolf
Jan 30, 2010·Bioinformatics·Aaron R Quinlan, Ira M Hall
Mar 3, 2010·PLoS Pathogens·Margalida RotgerUNKNOWN Center for HIV/AIDS Vaccine Immunology
Feb 1, 2011·Bioinformatics·Robert Schmieder, Robert Edwards
Feb 25, 2011·Nucleic Acids Research·Kimiko M TsutsuiKen Tsutsui
Aug 19, 2011·Epigenetics : Official Journal of the DNA Methylation Society·Paul A Del Rizzo, Raymond C Trievel
Jan 11, 2012·Proceedings of the National Academy of Sciences of the United States of America·Katsuyuki ShiroguchiX Sunney Xie
Oct 30, 2012·Bioinformatics·Alexander DobinThomas R Gingeras
Dec 21, 2012·The Journal of Experimental Medicine·Matthieu PerreauGiuseppe Pantaleo
Jan 18, 2013·BMC Bioinformatics·Sonja HänzelmannJustin Guinney
Dec 25, 2013·Proceedings of the National Academy of Sciences of the United States of America·Huasong LuQiang Zhou
Dec 18, 2014·Genome Biology·Michael I LoveSimon Anders
Jan 13, 2015·Scientific Reports·Yuka MatsudaMakoto Yamagishi
Jan 31, 2015·Cell·Lillian B CohnMichel C Nussenzweig
Feb 10, 2016·Proceedings of the National Academy of Sciences of the United States of America·Francesco R SimonettiFrank Maldarelli
Feb 26, 2016·Annual Review of Immunology·Carola G VinuesaIan C M MacLennan

❮ Previous
Next ❯

Citations

Sep 24, 2020·Scientific Data·Scott A OchsnerNeil J McKenna

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.